Startseite Optimal glucose and inoculum concentrations for production of bioactive molecules by Paenibacillus polymyxa RNC-D
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Optimal glucose and inoculum concentrations for production of bioactive molecules by Paenibacillus polymyxa RNC-D

  • Nadja Serrano EMAIL logo , Ligia Rodrigues , Carlos Hokka , Cristina Sousa , José Teixeira und Solange Mussatto
Veröffentlicht/Copyright: 13. September 2012
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

The production of antimicrobial metabolites by Paenibacillus polymyxa RNC-D was assessed. Two process variables, glucose and inoculum concentrations, were evaluated at different levels (5–40 g L−1, and at φ r = 2.5–5.0 %, respectively), and their effects on biomass formation, minimal inhibitory concentration (MIC) against Escherichia coli, and surface tension reduction (STR) were studied. When the fermentation process was carried out under non-optimised conditions, the biomass, MIC, and STR achieved the following values: 0.6 g L−1, 1 g L−1, and 18.4 mN m−1, respectively. The optimum glucose (16 g L−1) and inoculum volume ratio (φ r = 5.0 %) were defined in order to maximise the biomass formation, with a low value of MIC and high STR of extract. The experiments carried out under optimal conditions showed the following values for the dependent variables: biomass concentration 2.05 g L−1, MIC 31.2 μg mL−1, and STR 10.7 mN m−1, which represented improvement of 241.7 %, 96.9 %, and 41.9 % for the responses of biomass, MIC, and STR, respectively. This is the first recorded study on the optimisation of culture conditions for the production of antimicrobial metabolites of P. polymyxa RNC-D, and constitutes an important step in the development of strategies to modulate the production of antimicrobial molecules by this microorganism at elevated levels.

[1] Adinarayana, K., Prabhakar, T., Srinivasulu, V., Anitha Rao, M., Jhansi Lakshmi, P., & Ellaiah, P. (2003). Optimization of process parameters for cephalosporin C production under solid state fermentation from Acremonium chrysogenum. Process Biochemistry, 39, 171–177. DOI: 10.1016/s0032-9592(03)00049-9. http://dx.doi.org/10.1016/S0032-9592(03)00049-910.1016/S0032-9592(03)00049-9Suche in Google Scholar

[2] Gogoi, D. K., Mazumder, S., Saikia, R., & Bora, T. C. (2008). Impact of submerged culture conditions on growth and bioactive metabolite produced by endophyte Hypocrea spp. NSF-08 isolated from Dillenia indica Linn. in North-East India. Journal de Mycologie Médicale/Journal of Medical Mycology, 18, 1–9. DOI: 10.1016/j.mycmed.2007.10.006. http://dx.doi.org/10.1016/j.mycmed.2007.10.00610.1016/j.mycmed.2007.10.006Suche in Google Scholar

[3] Ito, M., & Koyama, Y. (1972a). Jolipeptin, a new peptide antibiotic. I. Isolation, physico-chemical and biological characteristics. The Journal of Antibiotics, 25, 304–308. DOI: 10.7164/antibiotics.25.304. http://dx.doi.org/10.7164/antibiotics.25.30410.7164/antibiotics.25.304Suche in Google Scholar

[4] Ito, M., & Koyama, Y. (1972b). Jolipeptin, a new peptide antibiotic. II. The mode of action of jolipeptin. The Journal of Antibiotics, 25, 309–314. DOI: 10.7164/antibiotics.25.309. http://dx.doi.org/10.7164/antibiotics.25.30910.7164/antibiotics.25.309Suche in Google Scholar PubMed

[5] Kajimura, Y., & Kaneda, M. (1996). Fusaricidin A, a new depsipeptide antibiotic produced by Bacillus polymyxa KT-8. Taxonomy, fermentation, isolation, structure elucidation and biological activity. The Journal of Antibiotics, 49, 129–135. DOI: 10.7164/antibiotics.49.129. http://dx.doi.org/10.7164/antibiotics.49.12910.7164/antibiotics.49.129Suche in Google Scholar PubMed

[6] Kajimura, Y., & Kaneda, M. (1997). Fusaricidins B, C, and D, new depsipeptide antibiotics produced by Bacillus polymyxa KT-8: Isolation, structure elucidation and biological activity. The Journal of Antibiotics, 50, 220–228. DOI: 10.7164/antibiotics.50.220. http://dx.doi.org/10.7164/antibiotics.50.22010.7164/antibiotics.50.220Suche in Google Scholar

[7] Katz, E., & Demain, A. L. (1977). The peptide antibiotics of Bacillus: chemistry, biogenesis, and possible functions. Bacteriology Reviews, 41, 449–474. 10.1128/br.41.2.449-474.1977Suche in Google Scholar PubMed PubMed Central

[8] Lam, K. S., Mattei, J., & Forenza, S. (1989). Carbon catabolite regulation of rebeccamycin production in Saccharothrix aerocolonigenes. Journal of Industrial Microbiology & Biotechnology, 4, 105–108. DOI: 10.1007/bf01569794. 10.1007/BF01569794Suche in Google Scholar

[9] Mussatto, S. I., & Roberto, I. C. (2008). Establishment of the optimum initial xylose concentration and nutritional supplementation of brewer’s spent grain hydrolysate for xylitol production by Candida guilliermondii. Process Biochemistry, 43, 540–546. DOI: 10.1016/j.procbio.2008.01.013. http://dx.doi.org/10.1016/j.procbio.2008.01.01310.1016/j.procbio.2008.01.013Suche in Google Scholar

[10] Nakajima, N., Chihara, S., & Koyama, Y. (1972). A new antibiotic, gatavalin. I. Isolation and characterization. The Journal of Antibiotics, 25, 243–247. DOI: 10.7164/antibiotics.25.243. 10.7164/antibiotics.25.243Suche in Google Scholar PubMed

[11] National Committee for Clinical Laboratory Standards (2002). Performance standards for antimicrobial susceptibility testing (12th Informational supplement). Wayne, PA, USA: Clinical and Laboratory Standards Institute. (M100-S12) Suche in Google Scholar

[12] Pichard, B., Larue, J. P., & Thouvenot, D. (1995). Gavaserin and saltavalin, new peptide antibiotics produced by Bacillus polymyxa. FEMS Microbiology Letters, 133, 215–218. DOI: 10.1111/j.1574-6968.1995.tb07887.x. http://dx.doi.org/10.1111/j.1574-6968.1995.tb07887.x10.1111/j.1574-6968.1995.tb07887.xSuche in Google Scholar PubMed

[13] Ratti, R. P., Serrano, N. F. G., Hokka, C. O., & Sousa, C. P. (2008). Antagonistic properties of some microorganisms isolated from Brazilian tropical savannah plants against Staphylococcus coagulase-positive strain. Journal of Venomous Animals and Toxins Including Tropical Diseases, 14, 294–302. DOI: 10.1590/s1678-91992008000200007. http://dx.doi.org/10.1590/S1678-9199200800020000710.1590/S1678-91992008000200007Suche in Google Scholar

[14] Raza, W., Wu, H. S., & Shen, Q. R. (2010). Use of response surface methodology to evaluate the effect of metal ions (Ca2+, Ni2+, Mn2+, Cu2+) on production of antifungal compounds by Paenibacillus polymyxa. Bioresource Technology, 101, 1904–1912. DOI: 10.1016/j.biortech.2009.10.029. http://dx.doi.org/10.1016/j.biortech.2009.10.02910.1016/j.biortech.2009.10.029Suche in Google Scholar PubMed

[15] Rodrigues, L. R., Teixeira, J. A., van der Mei, H. C., & Oliveira, R. (2006). Isolation and partial characterization of a biosurfactant produced by Streptococcus thermophilus A. Colloids and Surfaces B: Biointerfaces, 53, 105–112. DOI: 10.1016/j.colsurfb.2006.08.009. http://dx.doi.org/10.1016/j.colsurfb.2006.08.00910.1016/j.colsurfb.2006.08.009Suche in Google Scholar PubMed

[16] Santos, J. C., Mussatto, S. I., Cunha, M. A. A., & Silva, S. S. (2005). Variables that affect xylitol production from sugarcane bagasse hydrolysate in a zeolite fluidized bed reactor. Biotechnology Progress, 21, 1639–1643. DOI: 10.1021/bp050219n. http://dx.doi.org/10.1021/bp050219n10.1021/bp050219nSuche in Google Scholar PubMed

[17] Schulz, B., Boyle, C., Draeger, S., Römmert, A. K., & Krohn, K. (2002). Endophytic fungi: a source of novel biologically active secondary metabolites. Mycological Research, 106, 996–1004. DOI: 10.1017/s0953756202006342. http://dx.doi.org/10.1017/S095375620200634210.1017/S0953756202006342Suche in Google Scholar

[18] Shen, J., Lu, Z.X., Bie, X.M., Lü, F. X., & Huang, X. Q. (2005). Media optimization for the novel antimicrobial peptide by Bacillus sp. fmbJ224. Chinese Journal of Biotechnology, 21, 609–614. (in Chinese) Suche in Google Scholar

[19] Sogn, J. A. (1976). Structure of the peptide antibiotic polypeptin. Journal of Medicinal Chemistry, 19, 1228–1231. DOI: 10.1021/jm00232a012. http://dx.doi.org/10.1021/jm00232a01210.1021/jm00232a012Suche in Google Scholar PubMed

[20] Strobel, G., Daisy, B., Castillo, U., & Harper, J. (2004). Natural products from endophytic microorganisms. Journal of Natural Products, 67, 257–268. DOI: 10.1021/np030397v. http://dx.doi.org/10.1021/np030397v10.1021/np030397vSuche in Google Scholar PubMed

[21] Wang, Z. W., & Liu, X. L. (2008). Medium optimization for antifungal active substances production from a newly isolated Paenibacillus sp. using response surface methodology. Bioresource Technology, 99, 8245–8251. DOI: 10.1016/j.biortech.2008.03.039. http://dx.doi.org/10.1016/j.biortech.2008.03.03910.1016/j.biortech.2008.03.039Suche in Google Scholar PubMed

[22] Wang, X., Huang, L., Kang, Z., Buchenauer, H., & Gao, X. (2010). Optimization of the fermentation process of Actinomycete strain Hhs.015T. Journal of Biomedicine and Biotechnology, 2010, 141876. DOI: 10.1155/2010/141876. 10.1155/2010/141876Suche in Google Scholar PubMed PubMed Central

Published Online: 2012-9-13
Published in Print: 2012-12-1

© 2012 Institute of Chemistry, Slovak Academy of Sciences

Heruntergeladen am 9.9.2025 von https://www.degruyterbrill.com/document/doi/10.2478/s11696-012-0242-3/pdf
Button zum nach oben scrollen